Hemophilia Alliance

🟦 Non-Member Event : 340B Grantee Spring Conference
2026-05-28 - 2026-05-30
Date: May 28 – 30 (Houston, TX)
Click here for info.

🟦 Non-Member Event : 340B Coalition Summer Conference
2026-07-13 - 2026-07-15
Date: July 13 – 15 (Washington, D.C.)
Click here for info.

🟥 Member Webinar : Hemophilia Alliance Hosts - An Update on Takeda’s Transformation, Supply Status, and Hemophilia A Treatments
2026-07-22 13:00 - 14:00 (America/New_York)
Date: Wednesday, July 22nd, 2026
Time: 1:00pm – 2:00pm ET

WEBINAR TOPIC:
An Update on Takeda’s Transformation, Supply Status, and Hemophilia A Treatments
OBJECTIVES:

To familiarize audiences with Takeda transformation update
To share reminder on the HEMOFIL® M & RECOMBINATE® supply status
To share HCP presentation focusing on the immunogenicity results of the ADYNOVATE phase 3 trial in previously untreated patients (PUPs) and attributes of ADVATE for previously treated patients (PTPs).

AUDIENCE:
All HTC Staff
SPEAKERS:
Dr. Jonathan Roberts is the Associate Medical Director and Associate Research Director at the Bleeding and Clotting Disorders Institute in Peoria, IL. He also serves as an Associate Professor of Pediatrics and Medicine at the University of Illinois College of Medicine in Peoria, IL.
Dr. Roberts’ research focuses on developing novel laboratory assays to improve the diagnosis of von Willebrand Disease (VWD) and enhancing individualized clinical management of hemophilia, VWD, and other rare bleeding disorders. He has received numerous young investigator research awards and has authored over 100 peer-reviewed research publications and abstracts. His work includes lead and senior author publications in prominent journals such as Blood, the Journal of Thrombosis and Haemostasias, and the New England Journal of Medicine. He has also secured grant funding from organizations such as the National Bleeding Disorders Foundation, the World Federation of Hemophilia, and the National Institutes of Health.

Carley Riehle has been with Takeda for nearly nine years and has built her career around supporting the bleeding disorder community. She began in the field, calling on HTCs, hospitals, and chapters before leading a team of field members, where she developed a deep appreciation for the strength and resilience of the community. She later transitioned to Takeda’s Payer Team, where she focused on creating and protecting access for patients on Takeda therapies. Most recently, Carley was promoted to National Director of Specialty Pharmacy, where she partners with national specialty pharmacies and the Hemophilia Alliance to strengthen Takeda’s relationships, support their members, and ultimately improve access for patients. She is passionate about building trusted partnerships and advancing meaningful support for the bleeding disorder community.

Natalie Wu, Head of Takeda’s US Hematology and Transplant Franchise is biopharmaceutical leader with over 25 years of diverse US and Global experience across Rare Diseases, Oncology, Diabetes, and Neuroscience. Natalie is passionate about building deep connections with the patient communities we serve and the healthcare and advocacy teams who work tirelessly to support patients in their quest for better health. She challenges the status quo to drive meaningful impact where unmet needs and heath inequities remain.

Nicole Loguidice, MBA is Director, Foundational Therapeutics Platform Access Operations at Takeda. With more than eight years of experience in patient access, she has led operations across Hematology, Rare Disease, Endocrinology, and Transplant programs. Nicole is passionate about developing patient-centered access solutions, fostering cross-functional collaboration, and advancing programs that support patients’ access to the therapies they need.

🟥 Member Webinar : Hemophilia Alliance Presents - A Webinar on Planning for Medicaid Work Requirements
2026-07-30 14:00 - 15:00 (America/New_York)

🟦 Non-Member Event : NBDF BDC
2026-08-13 - 2026-08-15
Date: August 13 – 15 (Orlando, FL)
Click here for info.

🟥 Member Webinar : New HANS PBM Agreement Opportunities
2026-08-26 13:00 - 14:00 (America/New_York)

🟥 Member Event : 2026 Fall Members Meeting & Hill Day
2026-09-27 18:30 - 2026-09-29 17:30 (America/New_York)
Date: September 27 – 29, 2026
Location: Washington, DC
Please note: this button will redirect you to Cvent, the Alliance’s NEW management registration platform.

Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.

🟦 Non-Member Event : FWGBD Annual Conference
2026-10-09 - 2026-10-11
Date: October 9 – 11 (Boston, MA)
Click here for info.

🟦 Non-Member Event : ATHN Data Summit
2026-10-21 - 2026-10-22
Date: October 21 – 22, 2026 (New Orleans, LA)
Click here for info.

🟦 Non-Member Event : ASH Annual Meeting & Exposition
2026-12-12 - 2026-12-15
Date: December 12 – 15 (New Orleans, LA)
Click here for info.

🟥 Member Event : 2027 MPBA Meeting
2027-01-24 18:30 - 2027-01-26 14:00 (America/Phoenix)
Date: January 24 – 26, 2027
Location: Salt Lake City, UT
Please note: this button will redirect you to Cvent, the Alliance’s NEW management registration platform.

Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
